EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies

Francisco C Almeida, Gabriel A Marx, Susan K Rohde, Mitzi M Gonzales, Carolina Maldonado-Díaz, Satomi Hiya, Kevin Clare, Jorge Samanamud, Cheyanne C Slocum, Justin Kauffman, Daniel G Koenigsberg, Victoria Flores-Almazan und 7 weitere

Alzheimer's & Dementia · 2025-08 · 21 (8)

DOI: 10.1002/alz.70575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 04.08.2025. Verfasst von Francisco C Almeida und 18 weiteren Autor:innen. Beteiligte Einrichtung: Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus Gualtar, Braga, Portugal. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Alzheimer Disease, Lewy Body Disease, Cognition. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, Texas Alzheimer's Research and Care Consortium (TARCC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION The presence and interaction of multiple comorbid neuropathologies are a major contributor to the worldwide dementia burden. METHODS We analyzed 1183 subjects from the National Alzheimer's Coordinating Center dataset with various combinations of isolated and mixed neurodegenerative pathologies and conducted mixed‐effects multiple linear regression modeling to comprehensively compare the neurocognitive and neuropsychological trajectories between groups over time. RESULTS In combination with Alzheimer's disease neuropathologic change, various combinations of limbic‐predominant age‐related transactive response DNA‐binding protein 43 encephalopathy, Lewy body dementia, and cerebrovascular disease further impair global cognition and specific neurocognitive domains; however, they do not appear to extensively affect the rate of decline with time across these domains, suggesting an additive but not synergistic effect. DISCUSSION These findings corroborate the known cumulative effects of mixed pathologies on cognition and add nuance to our understanding of their specific interactions, which is crucial for the development of biomarkers and effective therapeutics. Highlights Mixed neurodegenerative pathologies are common in the elderly population. The most common neurodegenerative pathologies were Alzheimer's disease neuropathologic change (ADNC), cerebrovascular disease (CVD), Lewy body dementia (LBD), and limbic‐predominant age‐related transactive response DNA‐binding protein 43 encephalopathy (LATE). The addition of various combinations of comorbid CVD, LBD, and LATE to ADNC worsened overall performance on cognitive and neuropsychological testing across time. In general, the addition of multiple comorbid neurodegenerative pathologies did not influence the rate of decline across the evaluated time period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesAlzheimer DiseaseLewy Body DiseaseCognitionCerebrovascular DisordersHumansMaleFemaleAgedNeuropsychological TestsAged, 80 and over

Stichwörter der Autor:innen

Alzheimer's disease neuropathologic change (ADNC)Clinical Dementia Rating (CDR)Lewy body dementiaMini‐Mental State Examination (MMSE)National Alzheimer's Coordinating Center (NACC)Pick's diseasecerebrovascular diseasefrontotemporal lobar dementia (FTLD)limbic‐predominant age‐related TDP‐43 encephalopathy (LATE)primary age‐related tauopathy (PART)progressive supranuclear palsy (PSP)

Autor:innen und Institutionen

  • Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus Gualtar, Braga, Portugal.
  • ICVS/3B's-PT Government Associate Laboratory, University of Minho, Campus Gualtar, Braga, Portugal.
  • Department of Neuroradiology, Centro Hospitalar Universitário do Porto, Porto, Portugal.
  • Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID-Profile: Timothy E Richardson

Förderung

  • NIA NIH HHS
  • Texas Alzheimer's Research and Care Consortium (TARCC)

Zitieren

APA

Almeida, F. C., Marx, G. A., Rohde, S. K., Gonzales, M. M., Maldonado-Díaz, C., Hiya, S., Clare, K., Samanamud, J., Slocum, C. C., Kauffman, J., Koenigsberg, D. G., Flores-Almazan, V., Crary, J. F., Farrell, K., White, C. L., Daoud, E. V., Walker, J. M., Oliveira, T. G., & Richardson, T. E. (2025). Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies. Alzheimer's & Dementia, 21(8). https://doi.org/10.1002/alz.70575

Vancouver

Almeida FC, Marx GA, Rohde SK, Gonzales MM, Maldonado-Díaz C, Hiya S, et al. Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies. Alzheimer's & Dementia. 2025;21(8). doi:10.1002/alz.70575

BibTeX
@article{Almeida2025,
  author = {Almeida, Francisco C and Marx, Gabriel A and Rohde, Susan K and Gonzales, Mitzi M and Maldonado-Díaz, Carolina and Hiya, Satomi and Clare, Kevin and Samanamud, Jorge and Slocum, Cheyanne C and Kauffman, Justin and Koenigsberg, Daniel G and Flores-Almazan, Victoria and Crary, John F and Farrell, Kurt and White, Charles L and Daoud, Elena V and Walker, Jamie M and Oliveira, Tiago Gil and Richardson, Timothy E},
  title = {Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {8},
  doi = {10.1002/alz.70575}
}
Kostenlos starten →